{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:14:54Z","timestamp":1789233294672,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p> Mycobacterium tuberculosis has instigated a serious challenge toward the effective treatment of\ntuberculosis. The reoccurrence of the resistant strains of the disease to accessible drugs\/medications has mandate for the\ndevelopment of more effective anti-tubercular agents with efficient activities. Time expended and costs in discovering and\nsynthesizing new hypothetical drugs with improved biological activity have been a major challenge toward the treatment\nof multi-drug resistance strain M. tuberculosis (TB). Meanwhile, to solve the problem stated, a new approach i.e. QSAR\nwhich establish connection between novel drugs with a better biological against M. tuberculosis is adopted. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The\nanti-tubercular model established in this study to forecast the biological activities of some anti-tubercular compounds\nselected and to design new hypothetical drugs is subjective to the molecular descriptors; MATS7s, SM1_DzZ,\nSpMin4_Bhv, TDB3v and RDF70v. Ligand-receptor interactions between quinoline derivatives and the receptor (DNA\ngyrase) was carried out using molecular docking technique by employing the PyRx virtual screening software and\ndiscovery studio visualizer software. Furthermore, docking study indicates that compounds 20 of the derivatives with\npromising biological activity have the utmost binding energy of -17.79 kcal\/mol. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Meanwhile, the interaction of\nthe standard drug; isoniazid with the target enzyme was observed with the binding energy -14.6 kcal\/mol which was\nsignificantly lesser than the binding energy of the ligand (compound 20).Therefore, compound 20 served as a template\nstructure to designed compounds with more efficient activities. Among the compounds designed; compounds 20p was\nobserved with better anti-tubercular activities with more prominent binding affinities of -24.3kcal\/mol. <\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title> Conclusion:<\/jats:title>\n<jats:p>The\npresumption of this research aid the medicinal chemists and pharmacist to design and synthesis a novel drug candidate\nagainst the tuberculosis. Moreover, in-vitro and in-vivo test could be carried out to validate the computational results.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409916666200625142447","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T07:08:45Z","timestamp":1593155325000},"page":"739-758","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-tubercular Modelling via QSAR Approach, In Silico Design and Virtual\nDocking Screening of Designed Hypothetical Inhibitors Against DNA\ngyrase Protein"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7750-8174","authenticated-orcid":true,"given":"Shola Elijah","family":"Adeniji","sequence":"first","affiliation":[{"name":"Chemistry department, Ahmadu Bello University, Zaria,Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/183141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/183141\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/183141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T07:42:55Z","timestamp":1642750975000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/183141\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409916666200625142447","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}